SCHEMBL8287183

SCHEMBL8287183

CNc1c(Nc2ccccc2)n(-c2ccccc2)c2nc(C)ccc2c1=O

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAT2A P31153 2/20 0.48
MAPK8 P45983 5/20 0.41
MAPK9 P45984 4/20 0.41
MAPK10 P53779 4/20 0.41
RXFP1 Q9HBX9 4/20 0.41
GSK3B P49841 3/20 0.40
CDK4 P11802 1/20 0.37
CCND1 P24385 1/20 0.37
CCND2 P30279 1/20 0.37
CCND3 P30281 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
ADORA1 P30542 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287156 0.93 MAT2A (0.50) MAT2AMAPK8MAPK9MAPK10RXFP1
SCHEMBL8287392 0.81 MAPK8 (0.47) MAT2AMAPK8MAPK9MAPK10RXFP1
SCHEMBL8285234 0.80 MAT2A (0.47) MAT2AMAPK8MAPK9MAPK10RXFP1
SCHEMBL8286133 0.80 MAT2A (0.50) MAT2AMAPK8MAPK9MAPK10RXFP1
SCHEMBL8287180 0.80 MAT2A (0.45) MAT2AMAPK8MAPK9MAPK10RXFP1
SCHEMBL8286135 0.78 MAT2A (0.46) MAT2AMAPK8MAPK9MAPK10RXFP1
SCHEMBL8285354 0.78 GSK3B (0.39) MAT2AGSK3BCDK4CCND1CCND2
SCHEMBL5871674 0.77 SMN1; SMN2 (0.50) MAT2AMAPK8MAPK9MAPK10SMN1; SMN2
SCHEMBL29305636 0.77 MAT2A (0.51) MAT2AMAPK8MAPK9MAPK10SMN1; SMN2
SCHEMBL7059471 0.76 MEN1 (0.41) MAT2AMAPK8MAPK9MAPK10GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed